Education
About Us
Working with TipRanks
Follow Us
Vaccinex Inc (VCNX)
OTHER OTC:VCNX
VCNX Stock Chart & Stats
$0.70
-$0.04(-3.99%)
At close: 4:00 PM EST
$0.70
-$0.04(-3.99%)
Day’s Range― - ―
52-Week Range$0.25 - $4.35
Previous CloseN/A
Volume245.00
Average Volume (3M)1.22K
Market Cap
$1.38M
Enterprise Value$5.57M
Total Cash (Recent Filing)$1.11M
Total Debt (Recent Filing)$25.00K
Price to Earnings (P/E)―
Beta2.26
Next Earnings
Nov 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,676,637
10 Day Avg. Volume776
30 Day Avg. Volume1,224
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.83
Price to Sales (P/S)3.42
P/FCF Ratio-0.13
Enterprise Value/Market Cap4.05
Enterprise Value/Revenue9.26
Enterprise Value/Gross Profit9.70
Enterprise Value/Ebitda-0.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Vaccinex News
VCNX FAQ
What was Vaccinex Inc’s price range in the past 12 months?
Vaccinex Inc lowest stock price was $0.25 and its highest was $4.35 in the past 12 months.
What is Vaccinex Inc’s market cap?
Vaccinex Inc’s market cap is $1.38M.
When is Vaccinex Inc’s upcoming earnings report date?
Vaccinex Inc’s upcoming earnings report date is Nov 17, 2025 which is 23 days ago.
How were Vaccinex Inc’s earnings last quarter?
Currently, no data Available
Is Vaccinex Inc overvalued?
According to Wall Street analysts Vaccinex Inc’s price is currently Overvalued.
Does Vaccinex Inc pay dividends?
Vaccinex Inc does not currently pay dividends.
What is Vaccinex Inc’s EPS estimate?
Vaccinex Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaccinex Inc have?
Vaccinex Inc has 2,676,637 shares outstanding.
What happened to Vaccinex Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Vaccinex Inc?
Currently, no hedge funds are holding shares in VCNX
Company Description
Vaccinex Inc
Vaccinex, Inc. (VCNX) is a biotechnology company focused on developing targeted therapeutics for the treatment of cancer and neurodegenerative diseases. The company specializes in monoclonal antibody technology and has several proprietary product candidates, including its lead drug candidate, VAC-1, which is designed to treat various solid tumors. Vaccinex operates primarily in the healthcare sector, seeking to address unmet medical needs through innovative treatments and therapies.
Technical Analysis
Theriva Biologics
―
GT Biopharma
―
Revelation Biosciences
―
CERo Therapeutics Holdings
―
Azitra Inc
―
Ownership Overview
―
Insiders
6.13% Other Institutional Investors
93.87% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---